CNS & Neurological Disorders - Drug Targets
Title:Editorial (Hot Topic: Neural Stem Cells and Neurodegeneration)
Volume: 11 Issue: 7
Author(s): Andreas Androutsellis-Theotokis and Oscar Arias-Carrion
Affiliation:
Export Options
About this article
Cite this article as:
Androutsellis-Theotokis Andreas and Arias-Carrion Oscar, Editorial (Hot Topic: Neural Stem Cells and Neurodegeneration), CNS & Neurological Disorders - Drug Targets 2012; 11 (7) . https://dx.doi.org/10.2174/1871527311201070803
DOI https://dx.doi.org/10.2174/1871527311201070803 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
14
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models
Current Alzheimer Research From Protein Communication to Drug Discovery
Current Topics in Medicinal Chemistry The Role of Autophagy: What can be Learned from the Genetic Forms of Amyotrophic Lateral Sclerosis
CNS & Neurological Disorders - Drug Targets Neurotrophic Factors in Parkinson’s Disease: What Have we Learned from Pre-Clinical and Clinical Studies?
Current Medicinal Chemistry Tardive Dyskinesia with Atypical Antipsychotic Drugs
Current Drug Therapy Implication of Oncogenic Signaling Pathways as a Treatment Strategy for Neurodegenerative Disorders – Contemporary Approaches
CNS & Neurological Disorders - Drug Targets At the “Junction” of Spinal Muscular Atrophy Pathogenesis: The Role of Neuromuscular Junction Dysfunction in SMA Disease Progression
Current Molecular Medicine Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders
Current Drug Metabolism Hypertension in Obstructive Sleep Apnoea
Vascular Disease Prevention (Discontinued) Neuroimaging of Narcolepsy
CNS & Neurological Disorders - Drug Targets Recent Applications of Replica-Exchange Molecular Dynamics Simulations of Biomolecules
Current Physical Chemistry Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease
Current Stem Cell Research & Therapy Recognition-induced Conformational Changes in Protein-Protein Docking
Current Pharmaceutical Biotechnology Pathophysiology of Blood-Brain Barrier in Brain Injury in Cold and Hot Environments: Novel Drug Targets for Neuroprotection
CNS & Neurological Disorders - Drug Targets Development and Evaluation of a Tactile Cognitive Function Test Device for Alzheimer’s Disease Early Detection
Neuroscience and Biomedical Engineering (Discontinued) Role of the Non-Receptor Tyrosine Kinase Fes in Cancer
Current Medicinal Chemistry Acamprosate: A Prototypic Neuromodulator in the Treatment of Alcohol Dependence
CNS & Neurological Disorders - Drug Targets Biofilms: An Extra Hurdle for Effective Antimicrobial Therapy
Current Pharmaceutical Design Molecular Mechanisms, Proteinopathies and Therapeutic Strategies in Neurodegenerative Disorders
Current Genomics Increased CRMP2 Phosphorylation is Observed in Alzheimers Disease; Does this Tell us Anything About Disease Development?
Current Alzheimer Research